WarfarinEmbryopathy following in-utero exposure: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1725卷 / 1期

关键词：

D O I：

10.1007/s40278-018-53634-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：293 / 293

相关论文

共 50 条

[1] WarfarinEmbryopathy following in-utero exposure: 2 case reports
Reactions Weekly, 2019, 1752 (1) : 387 - 387
[2] WarfarinEmbryopathy following in utero exposure: case report
Reactions Weekly, 2010, 1327 (1) : 36 - 36
[3] WarfarinEmbryopathy following in utero exposure: case report
Reactions Weekly, 2011, 1368 (1) : 42 - 42
[4] WarfarinEmbryopathy following in utero exposure: case report
Reactions Weekly, 2011, 1356 (1) : 34 - 34
[5] DexamethasoneHypospadias following in-utero exposure: case report
Reactions Weekly, 2022, 1927 (1) : 217 - 217
[6] ThiamazoleGastroschisis following in-utero exposure: case report
Reactions Weekly, 2019, 1759 (1) : 250 - 250
[7] ColecalciferolHypercalcaemia following in-utero exposure: case report
Reactions Weekly, 2017, 1667 (1) : 92 - 92
[8] MetyraponeHyponatraemia following in-utero exposure: case report
Reactions Weekly, 2020, 1811 (1) : 186 - 186
[9] PropranololHypoglycaemia following in-utero exposure: case report
Reactions Weekly, 2016, 1611 (1) : 146 - 146
[10] AdalimumabExencephaly following in-utero exposure: case report
Reactions Weekly, 2021, 1843 (1) : 17 - 17

← 1 2 3 4 5 →